QUIDELORTHO CORP Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
QUIDELORTHO CORP (QDEL) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of $5.20 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2026-08-07
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2026-06-28 was $5.20M.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2026-03-29 was $21.80M.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-12-28 was $300.00K, a 99.29% decline year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-09-28 was -$9.10M.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2025 was -$31.30M, a 160.08% decline from fiscal 2024.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2024 was $52.10M, a 313.49% increase from fiscal 2023.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2023 was $12.60M, a 88.06% increase from fiscal 2023.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2023 was $6.70M, a 6600.00% increase from fiscal 2022.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2026-06-28 | $5.20M 10-Q · filed 2026-08-07 | $27.00M 10-Q · filed 2026-08-07 | $27.30M derived: sum of 3 quarters · filed 2026-08-07 | $18.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $21.80M 10-Q · filed 2026-05-06 | $22.10M derived: sum of 2 quarters · filed 2026-05-06 | $13.00M derived: sum of 3 quarters · filed 2026-05-06 | $6.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$8.80M derived: sum of 2 quarters · filed 2026-02-19 | -$15.10M derived: sum of 3 quarters · filed 2026-08-07 | -$31.30M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$9.10M 10-Q · filed 2025-11-06 | -$15.40M derived: sum of 2 quarters · filed 2026-08-07 | -$31.60M 10-Q · filed 2025-11-06 | $10.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$6.30M 10-Q · filed 2026-08-07 | -$22.50M 10-Q · filed 2026-08-07 | $19.70M derived: sum of 3 quarters · filed 2026-08-07 | -$14.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | -$16.20M 10-Q · filed 2026-05-06 | $26.00M derived: sum of 2 quarters · filed 2026-05-06 | -$7.70M derived: sum of 3 quarters · filed 2026-05-06 | $5.40M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $42.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $8.50M derived: sum of 2 quarters · filed 2026-02-19 | $21.60M derived: sum of 3 quarters · filed 2026-02-19 | $52.10M 10-K · filed 2026-02-19 |
| 2024-09-29 | -$33.70M 10-Q · filed 2025-11-06 | -$20.60M derived: sum of 2 quarters · filed 2025-11-06 | $9.90M 10-Q · filed 2025-11-06 | -$25.10M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $13.10M 10-Q · filed 2025-08-06 | $43.60M 10-Q · filed 2025-08-06 | $8.60M derived: sum of 3 quarters · filed 2026-02-19 | $33.10M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $30.50M 10-Q · filed 2025-05-08 | -$4.50M derived: sum of 2 quarters · filed 2026-02-19 | $20.00M derived: sum of 3 quarters · filed 2026-02-19 | $60.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$10.50M derived: sum of 2 quarters · filed 2026-02-19 | $29.50M derived: sum of 3 quarters · filed 2026-02-19 | $12.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | $24.50M 10-Q · filed 2024-11-08 | $64.50M derived: sum of 2 quarters · filed 2024-11-08 | $47.60M 10-Q · filed 2024-11-08 | $40.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $40.00M 10-Q · filed 2024-08-01 | $23.10M 10-Q · filed 2024-08-01 | $15.90M derived: sum of 3 quarters · filed 2025-02-27 | $25.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$16.90M 10-Q · filed 2024-05-09 | -$24.10M derived: sum of 2 quarters · filed 2025-02-27 | -$14.80M derived: sum of 3 quarters · filed 2025-02-27 | -$10.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | -$7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.10M derived: sum of 2 quarters · filed 2025-02-27 | $6.50M derived: sum of 3 quarters · filed 2025-02-27 | $6.70M 10-K · filed 2025-02-27 |
| 2022-10-02 | $9.30M 10-Q · filed 2023-11-02 | $13.70M derived: sum of 2 quarters · filed 2023-11-02 | $13.90M 10-Q · filed 2023-11-02 | $13.80M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $4.40M 10-Q · filed 2023-08-09 | $4.60M 10-Q · filed 2023-08-09 | $4.50M derived: sum of 3 quarters · filed 2024-08-01 | $4.50M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $100.00K 10-Q · filed 2023-05-04 | $100.00K derived: sum of 2 quarters · filed 2024-08-01 | $100.00K derived: sum of 3 quarters · filed 2024-08-01 | -$100.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-01-02 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $0.00 derived: sum of 2 quarters · filed 2024-08-01 | -$200.00K derived: sum of 3 quarters · filed 2024-08-01 | $100.00K 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $0.00 10-Q · filed 2022-11-04 | -$200.00K derived: sum of 2 quarters · filed 2022-11-04 | $100.00K 10-Q · filed 2022-11-04 | |
| 2021-07-04 | -$200.00K 10-Q · filed 2022-08-05 | $100.00K 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | -$3.00M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |